4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001562180-20-000119
Chief Medical Officer sold 11,294 shares at $15.04 ($169,817)
- Chief Medical Officer acquired 11,294 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS JOHN C. JR Chief Medical Officer | 2020-01-02 | Option exercise | +11,294 | $9.49 | $107,180 | 19,598 | D |
| DAVIS JOHN C. JR Chief Medical Officer | 2020-01-02 | Sale | −11,294 | $15.04 | $169,817 | 8,304 | D |
| Derivatives | |||||||
| DAVIS JOHN C. JR Chief Medical Officer | 2020-01-02 | Option exercise · Stock Option (Right to Buy) | −11,294 | 224,831 | D | ||
| Open-market sales · 11,294 sh · avg $15.04 · $169,817 | |||||||
Loading xslF345X03/primarydocument.xml…